Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea

Summary

This study aims to provide high-level evidence for appropriate empirical antibiotic use tailored to the clinical reality in Korea by conducting a randomized controlled trial comparing monotherapy with piperacillin/tazobactam and combination therapy with piperacillin/tazobactam plus a fluoroquinolone in patients with severe community-acquired pneumonia.

Timeline

Start

2025-06-15

Primary completion

2026-12-31

Completion

2027-02-01

Drugs

Indications